Vanessa Research reports that its MIDA (Microvillus Inclusion Disease Assay) project, under the direction of Dr. Ludmila Kvochina, has been accepted into the 2019 cohort of the highly selective Accelerator for Biosciences in Connecticut (ABCT).

MIDA is the first-ever dipstick test developed to screen for the incredibly rare and lethal microvillus inclusion disease.